• 대한부인종양학회

    Korean Society of Gynecologic Oncology

    MISSION

    부인암 정복을 통해, 치명적 위협으로부터
    여성을 보호한다.

    Protecting women from fatal threats by conquering
    gynecologic cancer

Association of Germiline BRCA Pathogenic Variants with Diminished..

Survival with Cemiplimab in Recurrent Cervical Cancer

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4): an international, open-label, randomised, phase 3 trial




[닫기]




[닫기]